Περίληψη:
To commemorate the auspicious occasion of the 30th anniversary of IPC, leading pioneers in the field of cardioprotection gathered in Barcelona in May 2016 to review and discuss the history of IPC, its evolution to IPost and RIC, myocardial reperfusion injury as a therapeutic target, and future targets and strategies for cardioprotection. This article provides an overview of the major topics discussed at this special meeting and underscores the huge importance and impact, the discovery of IPC has made in the field of cardiovascular research. © 2016, The Author(s).
Συγγραφείς:
Hausenloy, D.J.
Barrabes, J.A.
Bøtker, H.E.
Davidson, S.M.
Di Lisa, F.
Downey, J.
Engstrom, T.
Ferdinandy, P.
Carbrera-Fuentes, H.A.
Heusch, G.
Ibanez, B.
Iliodromitis, E.K.
Inserte, J.
Jennings, R.
Kalia, N.
Kharbanda, R.
Lecour, S.
Marber, M.
Miura, T.
Ovize, M.
Perez-Pinzon, M.A.
Piper, H.M.
Przyklenk, K.
Schmidt, M.R.
Redington, A.
Ruiz-Meana, M.
Vilahur, G.
Vinten-Johansen, J.
Yellon, D.M.
Garcia-Dorado, D.
Λέξεις-κλειδιά:
cariporide; cyclosporin A; exendin 4; glucagon like peptide 1; glucagon like peptide 1 derivative; glyceryl trinitrate; high density lipoprotein; melatonin; metoprolol; mitogen activated protein kinase 1; mitogen activated protein kinase 3; protein kinase B; purinergic P2Y12 receptor; purinergic receptor blocking agent, combination drug therapy; drug targeting; heart infarction prevention; heart muscle reperfusion; heart protection; human; ischemic postconditioning; ischemic preconditioning; mitochondrion; myocardial ischemia reperfusion injury; nonhuman; protein function; randomized controlled trial (topic); remote ischemic conditioning; remote ischemic preconditioning; Review; second window of protection; signal transduction; ST segment elevation myocardial infarction; therapy effect; translational research; animal; myocardial ischemia reperfusion injury, Animals; Humans; Ischemic Preconditioning, Myocardial; Myocardial Reperfusion Injury
